Search for: "Ariad Pharmaceuticals Inc."
Results 1 - 20
of 103
Sorted by Relevance
|
Sort by Date
1 Jun 2009, 9:58 pm
Ariad Pharmaceuticals, Inc., dealing another blow to Ariad Pharmaceuticals and U.S. [read post]
6 Apr 2009, 7:15 pm
By Andrew Williams -- On Friday, the Federal Circuit issued its decision in Ariad Pharmaceuticals, Inc. v. [read post]
3 Jun 2009, 9:50 pm
By Donald Zuhn -- Yesterday, Ariad Pharmaceuticals filed a petition for a panel rehearing of the decision issued by the Federal Circuit in Ariad Pharmaceuticals, Inc. v. [read post]
10 Dec 2009, 9:50 pm
By Donald Zuhn -- On Monday, an en banc panel of the Federal Circuit heard oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
22 Sep 2008, 6:41 am
The Boston Globe noted: Ariad Pharmaceuticals Inc. of Cambridge said Sept. 22 that it plans to pursue the "appropriate legal action" after a federal judge ruled against it in a patent dispute.See alsoMore on Ariad/Lilly [read post]
15 Apr 2007, 2:42 am
Further to discussion about Ariad's US patent 6,410,516, the AP reported on April 13:Ariad Pharmaceuticals Inc. said late Friday [April 13] it filed a counter claim against Amgen Inc. over the patent to methods of treating human disease by regulating NF-(kappa)B cell-signaling activity.The claim _ which is also against drug maker Wyeth _ is a response to a lawsuit filed by Amgen against Ariad, saying the company's claims to the patent… [read post]
6 Oct 2008, 6:15 am
Del. has granted Ariad leave for immediate appeal to the CAFC of the adverse summary judgment ruling.The Boston Globe noted: Ariad Pharmaceuticals Inc. of Cambridge said today [Oct. 6] that a federal judge has granted its request to permit an immediate appeal of the court's ruling against Ariad in a patent infringement case.In its summary judgment ruling, the US District Court for the District of Delaware found that the administration of Enbrel, a… [read post]
10 Nov 2009, 9:59 pm
By Donald Zuhn -- With oral argument before the Supreme Court in In re Bilski now concluded, patent practitioners can begin to turn their attention toward the next big patent case awaiting oral argument: the Federal Circuit's en banc rehearing of Ariad Pharmaceuticals, Inc. v. [read post]
21 Aug 2009, 2:50 pm
By Donald Zuhn -- The Court of Appeals for the Federal Circuit today decided that the appeal in Ariad Pharmaceuticals, Inc. v. [read post]
23 Nov 2009, 9:59 pm
By Donald Zuhn -- With oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
14 Dec 2009, 9:59 pm
Noonan -- At the outset of the en banc oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
9 Dec 2009, 9:24 pm
Noonan -- Oral argument in Ariad Pharmaceuticals, Inc. v. [read post]
16 Nov 2009, 9:59 pm
By Donald Zuhn -- Last week, Defendant-Appellant Eli Lilly & Co. filed its principal brief for the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
19 Nov 2009, 9:59 pm
Holman, Associate Professor of Law at the University of Missouri-Kansas City (and proprietor of Holman's Biotech IP Blog), has filed an amicus brief in support of neither party in Ariad Pharmaceuticals, Inc. v. [read post]
10 Jul 2007, 9:51 pm
By Donald Zuhn -- On Monday, ARIAD Pharmaceuticals, Inc. announced that the U.S. [read post]
24 Nov 2009, 9:59 pm
By Donald Zuhn -- In anticipation of the upcoming oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
9 Jul 2007, 9:04 pm
On July 9, Reuters reported: Ariad Pharmaceuticals Inc. said a U.S. federal court ruled in favor of it and co-complainants in a patent infringement case against Eli Lilly and Co., saying that the patent was valid and enforceable.Within the Reuters report, one also has mention of a final rejection in a re-examination of the patent at issue: Ariad also said that the U.S. [read post]
12 Apr 2010, 11:44 am
Following on the heels of the Federal Circuit en banc opinion in Ariad Pharmaceuticals, Inc. v. [read post]
21 Jun 2020, 8:15 pm
Eli Lilly & Co. and "Ariad Pharmaceuticals Inc. v. [read post]
17 Apr 2007, 8:58 pm
By Sherri Oslick -- In a recent press release, ARIAD Pharmaceuticals, Inc. announced that it has filed suit against Amgen Inc., certain Amgen affiliates, and Wyeth for infringement of U.S. [read post]
